Can Ringer Lactate Used As Perfusion Fluid In Live Donor Renal Transplant?
Phase 2
Completed
- Conditions
- Health Condition 1: N186- End stage renal disease
- Registration Number
- CTRI/2018/05/014211
- Lead Sponsor
- RENAL TRANSPLANT SURGERY DEPARTMENT
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
Undergoing renal transplant after giving consent for the study
Exclusion Criteria
1 Complex vascular anatomy requiring prolonged bench reconstruction estimated > 3 hours
2 Cadaveric transplant
3 Repeat implantation
4 Non adherence with study protocol
5 Myocardial infarction within the last 6 months or active Myocardial Ischaemia
6 Transient ischemic attack or stroke within the last 6 months
7 Severe restrictive or obstructive pulmonary disease
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method